Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Jupiter Neurosciences, Inc. - Common Stock
(NQ:
JUNS
)
0.2142
+0.0042 (+2.00%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Jupiter Neurosciences, Inc. - Common Stock
< Previous
1
2
3
Next >
Which stocks are experiencing notable movement on Monday?
↗
June 29, 2026
Via
Chartmill
What's going on in today's session
↗
June 29, 2026
Via
Chartmill
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
June 29, 2026
Via
Chartmill
Get insights into the top gainers and losers of Monday's pre-market session.
↗
June 29, 2026
Via
Chartmill
Friday's after hours session: top gainers and losers
↗
June 26, 2026
Via
Chartmill
MissionIRNewsBreaks – Jupiter Neurosciences Inc. (NASDAQ: JUNS) Closes $2 Million Registered Direct Offering
May 28, 2026
Via
Investor Brand Network
D. Boral Capital Acted as Exclusive Placement Agent to Jupiter Neurosciences, Inc. (Nasdaq:JUNS) in Connection with its ~$2 Million Registered Direct Offering
May 26, 2026
Via
ACCESS Newswire
What's going on in today's after hours session
↗
May 21, 2026
Via
Chartmill
The trading volume of these stocks is deviating from the norm in today's session.
↗
May 21, 2026
Via
Chartmill
Most active stocks in Wednesday's session
↗
May 20, 2026
Via
Chartmill
Traders are paying attention to the gapping stocks in Wednesday's session.
↗
May 20, 2026
Via
Chartmill
Stay updated with the stocks that are on the move in today's pre-market session.
↗
May 20, 2026
Via
Chartmill
Top movers in Monday's pre-market session
↗
April 20, 2026
Via
Chartmill
Jupiter Neurosciences Investor News: Rosen Law Firm Encourages Jupiter Neurosciences, Inc. Investors to Inquire About Securities Class Action Investigation – JUNS
April 13, 2026
From
Rosen Law Firm
Via
Business Wire
Rosen Law Firm Encourages Jupiter Neurosciences, Inc. Investors to Inquire About Securities Class Action Investigation – JUNS
April 12, 2026
From
The Rosen Law Firm, P.A.
Via
Business Wire
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
March 13, 2026
From
Virtual Investor Conferences
Via
GlobeNewswire
Life Sciences Virtual Investor Forum Agenda Announced for March 11th & 12th
March 10, 2026
Company Executives Share Strategic Vision and Engage with Investors Live at VirtualInvestorConferences.com
From
Virtual Investor Conferences
Via
GlobeNewswire
Jupiter Neurosciences Selected as B2i Digital Featured Company
February 12, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Jupiter Neurosciences Selected as B2i Digital Featured Company
February 12, 2026
Clinical-Stage Pharmaceutical Company Advancing Phase IIa Parkinson’s Trial
Via
TheNewswire.com
Unusual volume stocks in Thursday's session
↗
January 29, 2026
Via
Chartmill
From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon
December 16, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
From FDA Clearance To The Launch Of A Consumer Line, Jupiter Neurosciences Hit Milestones In 2025; More On The Horizon
December 16, 2025
Via
TheNewswire.com
Jupiter Neurosciences Brings Its Brain Health Expertise To The Masses With Nugevia - And A Range Of Celebs From Athletes To Scientists Are Customers
November 06, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Jupiter Neurosciences Brings Its Brain Health Expertise To The Masses With Nugevia - And A Range Of Celebs From Athletes To Scientists Are Customers
November 06, 2025
Via
TheNewswire.com
Jupiter Neurosciences CEO And President Talk About The Power of JOTROL And The Launch of Its Longevity Consumer Line With Benzinga
August 21, 2025
Via
TheNewswire.com
Jupiter Neurosciences CEO And President Talk About The Power of JOTROL And The Launch of Its Longevity Consumer Line With Benzinga
August 21, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia(TM) Brand
August 19, 2025
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Longevity In A Capsule: Jupiter Neurosciences Launches First Three Supplements Under Nugevia(TM) Brand
August 19, 2025
Via
TheNewswire.com
There are notable gap-ups and gap-downs in today's session.
↗
August 14, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Thursday.
Via
Chartmill
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
July 17, 2025
Via
Benzinga
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.